Seegene Presents Its Multi-Technology at ADLM 2024 Page 1

Seegene (KQ096530), a leading South Korean company
Provides a complete solution for molecular PCR diagnostics, introduced by
The most important products and systems of the Diagnostic and Diagnostic Society
Laboratory Medicine 2024 (ADLM 2024) under the exhibition slogan “One Sample,
Many answers.” The event took place from July 30 to August 1 in Chicago.
instead of.

The company launched its range of multiplexed real-time PCR products,
Which can be used to identify multiple targets in a single test.
These tests include IVDR tests used outside the United States to diagnose:
Respiratory tract infections (RP), gastrointestinal tract infections (GI), and sexual infections
STIs, infections caused by human papillomaviruses (HPV)
Antimicrobial resistance (AMR). Test procedures
Seegene also appeared on video screens at the company's booth.
It is shown.

In addition to its flagship product, Seegene STARlet-AIOS(TM) (AIOS).
Seegene offers its own automated testing systems, such as the Seegene NIMBUS,
Offering different automation solutions depending on size and space.
Designed for the needs of different testing laboratories.

AIOS features a seamless modular design.
Existing tools such as DNA extraction machines, PCR machines and
Integrated PCR Tools. AIOS is developed to support the PCR testing process.
From DNA extraction to gene amplification to
Automate data analysis and those resulting from human errors
Reduce contamination. Once samples are introduced, this results in
The system automatically performs tests and provides results.

“ADLM 2024 was a great opportunity for Seegene, our company
Multiplexing PCR technology combined with assays and automation
“Testing systems are all over the world,” said Daniel Shen, executive vice president.
and Global Sales and Marketing Director at Seegene. “Segene continues,
Strives to maintain its position as a leading company in the field of molecular diagnostics in the world.
By promoting its business areas comprehensively and actively.
Potential partners in achieving a “disease-free world”
It has been identified.”

Seegene's PCR molecular diagnostic technology enables simultaneous screening